3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
10
Uterine Cervical Neoplasms
9
Lung Neoplasms
7
Carcinoma, Non-Small-Cell Lung
7
Urinary Bladder Neoplasms
5
Stomach Neoplasms
5
Small Cell Lung Carcinoma
4
Mesothelioma, Malignant
4
Medulloblastoma
4
Urethral Neoplasms
3
Oropharyngeal Neoplasms
3
Neuroblastoma
3
Head and Neck Neoplasms
3
Ganglioneuroblastoma
3
Cholangiocarcinoma
3
Vulvar Neoplasms
2
Vaginal Neoplasms
2
Ureteral Neoplasms
2
Tongue Neoplasms
2
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Lymphoid Interstitial Pneumonia
2
Gallbladder Neoplasms
2
Fallopian Tube Neoplasms
2
Esophageal Neoplasms
2
Carcinoma, Transitional Cell
2
Carcinoma, Hepatocellular
2
Brenner Tumor
2
Brain Neoplasms
2
Vomiting
1
Interventions
Ipilimumab
10
tremelimumab
6
durvalumab
5
Nivolumab
3
pembrolizumab
2
tilsotolimod
1
spartalizumab
1
relatlimab
1
folfirinox
1
balstilimab
1
Vemurafenib
1
Vaccines
1
Radiotherapy
1
Radiofrequency Ablation
1
Radiation
1
Paclitaxel
1
Oxaliplatin
1
Opdualag
1
Melphalan
1
Leucovorin
1
Fluorouracil
1
Docetaxel
1
Cryosurgery
1
Carboplatin
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Diabetes Mellitus, Insulin-Dependent, 12
×
Platinum
×
Clear all
No trials found.